| Efficacy and safety of short-term (<=6 months) duration of dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomized controlled trials | Chun-Lin XİANG,Yi-Zhen GONG,Long-Jia ZENG,Bei-Bei LUO,Jian XU,Yan HE | 168–175 |
| The effect of nandrolone treatment with and without enforced swimming on histological and biochemical changes in the heart and coronary artery of male rats | Asghar TOFİGHİ,Minoo SHİRPOOR,Mohammad Hasan Khadem ANSARİ,Alireza SHİRPOOR,Mitra ZEREHPOOSH | 176–183 |
| The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure | Erkan YILDIRIM,Mahir CENGİZ,Nilgün YILDIRIM,Kürşat ASLAN,Emrah İPEK,Ali Fuat KORKMAZ,Fatih RIFAT ULUSOY,Engin HATEM | 184–190 |
| Fasting glycemia and glycated hemoglobin categories: Relationship to serum lipoprotein(a) level and disparity in 2 geographic regional groups of Turkey | Altan ONAT,Yusuf KARADENİZ,GÜNAY CAN,Süleyman KARAKOYUN,Fatma KARADENIZ ÖZPAMUK,AYŞEM KAYA,Hüsniye YÜKSEL | 191–199 |
| Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk? | Marija VAVLUKİS | 200–201 |
| Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study | Servet ALTAY,Hüseyin Altuğ ÇAKMAK,Tuğba ÖZ KEMALOĞLU,Fatma KARADENIZ ÖZPAMUK,Ayça TÜRER,Hatice Betül ERER,Gülen Feyzan KILIÇ,İbrahim KELEŞ,GÜNAY CAN,Mehmet EREN | 202–209 |
| The impact of protein oxidation on sustained and white coat hypertension | Erkan YILDIRIM,Emrah İPEK,IŞIL BAVUNOĞLU,Nilgün YILDIRIM,Mahir CENGİZ,Serap YAVUZER,Hakan YAVUZER,Hayriye ERMAN,HAFİZE UZUN | 210–216 |
| NKX2-5 molecular screening and assessment of variant rate and risk factors of secundum atrial septal defect in a Moroccan population | Ihssane El BOUCHİKHİ,Laila BOUGUENOUCH,Fatima Zohra MOUFİD,Mohammed Iraqui HOUSSAİNİ,Khadija BELHASSAN,Imane SAMRI,Ayoub Tahri JOUTEİ,Karim OULDIM,Samir ATMANI | 217–223 |
| Release of mitochondrial DNA correlates with peak inflammatory cytokines in patients with acute myocardial infarction | Chaoyi QİN,Jun GU,Ruiqi LİU,Fei XU,Hong QİAN,Qian HE,Wei MENG |